APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Phenylpropanolamine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Phenylpropanolamine Industry Growth and Trends Forecast to 2032

Report ID 174025430119 December 2025110 pages

Choose your research edition.

Industry ResearchPhenylpropanolamine Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Phenylpropanolamine Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Phenylpropanolamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phenylpropanolamine Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Phenylpropanolamine Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Phenylpropanolamine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Phenylpropanolamine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Phenylpropanolamine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phenylpropanolamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Phenylpropanolamine include Abbott, GlaxoSmithKline (GSK), Tempo Scan Pacific, Schazoo, Sanofi-Aventis, Roemmers, Riemser Pharma, Medlink and Meda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Phenylpropanolamine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Phenylpropanolamine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Phenylpropanolamine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Phenylpropanolamine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Phenylpropanolamine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Phenylpropanolamine Market by Company

Abbott

GlaxoSmithKline (GSK)

Tempo Scan Pacific

Schazoo

Sanofi-Aventis

Roemmers

Riemser Pharma

Medlink

Meda

IBL Healthcare

Helicon

Gräub

Gracia Pharmindo

Eipico

Carinopharm

Asuncion

Armoxindo

Phenylpropanolamine Segment by Type

Capsule

Tablet

Syrup

Phenylpropanolamine Segment by Application

Human

Veterinary

Phenylpropanolamine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phenylpropanolamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phenylpropanolamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phenylpropanolamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Phenylpropanolamine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Phenylpropanolamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsule Table 2. Major Company of Tablet Table 3. Major Company of Syrup Table 4. Global Phenylpropanolamine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Phenylpropanolamine Sales by Type (2021-2026) & (K Units) Table 6. Global Phenylpropanolamine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Phenylpropanolamine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Phenylpropanolamine Sales Market Share in Value by Type (2021-2026) Table 9. Global Phenylpropanolamine Price by Type (2021-2026) & (US$/Unit) Table 10. Global Phenylpropanolamine Sales by Type (2027-2032) & (K Units) Table 11. Global Phenylpropanolamine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Phenylpropanolamine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Phenylpropanolamine Sales Market Share in Value by Type (2027-2032) Table 14. Global Phenylpropanolamine Price by Type (2027-2032) & (US$/Unit) Table 15. North America Phenylpropanolamine Sales by Type (2021-2026) & (K Units) Table 16. North America Phenylpropanolamine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Phenylpropanolamine Sales by Type (2021-2026) & (K Units) Table 18. Europe Phenylpropanolamine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Phenylpropanolamine Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Phenylpropanolamine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Phenylpropanolamine Sales by Type (2021-2026) & (K Units) Table 22. Latin America Phenylpropanolamine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Phenylpropanolamine Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Phenylpropanolamine Sales by Type (2021-2026) & (US$ Million) Table 25. Phenylpropanolamine Industry Trends Table 26. Phenylpropanolamine Industry Drivers Table 27. Phenylpropanolamine Industry Opportunities and Challenges Table 28. Phenylpropanolamine Industry Restraints Table 29. Global Phenylpropanolamine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Phenylpropanolamine Revenue Market Share by Company (2021-2026) Table 31. Global Phenylpropanolamine Sales by Company (2021-2026) & (K Units) Table 32. Global Phenylpropanolamine Sales Share by Company (2021-2026) Table 33. Global Phenylpropanolamine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Phenylpropanolamine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Phenylpropanolamine Major Company Production Sites and Headquarters Table 36. Global Phenylpropanolamine Company, Product Type & Application Table 37. Global Phenylpropanolamine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Phenylpropanolamine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Phenylpropanolamine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Phenylpropanolamine Sales by Region (2021-2026) & (K Units) Table 42. Global Phenylpropanolamine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Phenylpropanolamine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Phenylpropanolamine Sales Market Share in Value by Region (2021-2026) Table 45. Global Phenylpropanolamine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Phenylpropanolamine Sales by Region (2027-2032) & (K Units) Table 47. Global Phenylpropanolamine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Phenylpropanolamine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Phenylpropanolamine Sales Market Share in Value by Region (2027-2032) Table 50. Global Phenylpropanolamine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Phenylpropanolamine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Phenylpropanolamine Sales by Application (2021-2026) & (K Units) Table 53. Global Phenylpropanolamine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Phenylpropanolamine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Phenylpropanolamine Sales Market Share in Value by Application (2021-2026) Table 56. Global Phenylpropanolamine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Phenylpropanolamine Sales by Application (2027-2032) & (K Units) Table 58. Global Phenylpropanolamine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Phenylpropanolamine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Phenylpropanolamine Sales Market Share in Value by Application (2027-2032) Table 61. Global Phenylpropanolamine Price by Application (2027-2032) & (US$/Unit) Table 62. North America Phenylpropanolamine Sales by Application (2021-2026) & (K Units) Table 63. North America Phenylpropanolamine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Phenylpropanolamine Sales by Application (2021-2026) & (K Units) Table 65. Europe Phenylpropanolamine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Phenylpropanolamine Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Phenylpropanolamine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Phenylpropanolamine Sales by Application (2021-2026) & (K Units) Table 69. Latin America Phenylpropanolamine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Phenylpropanolamine Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Phenylpropanolamine Sales by Application (2021-2026) & (US$ Million) Table 72. Abbott Company Information Table 73. Abbott Business Overview Table 74. Abbott Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Abbott Phenylpropanolamine Product Portfolio Table 76. Abbott Recent Development Table 77. GlaxoSmithKline (GSK) Company Information Table 78. GlaxoSmithKline (GSK) Business Overview Table 79. GlaxoSmithKline (GSK) Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. GlaxoSmithKline (GSK) Phenylpropanolamine Product Portfolio Table 81. GlaxoSmithKline (GSK) Recent Development Table 82. Tempo Scan Pacific Company Information Table 83. Tempo Scan Pacific Business Overview Table 84. Tempo Scan Pacific Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Tempo Scan Pacific Phenylpropanolamine Product Portfolio Table 86. Tempo Scan Pacific Recent Development Table 87. Schazoo Company Information Table 88. Schazoo Business Overview Table 89. Schazoo Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Schazoo Phenylpropanolamine Product Portfolio Table 91. Schazoo Recent Development Table 92. Sanofi-Aventis Company Information Table 93. Sanofi-Aventis Business Overview Table 94. Sanofi-Aventis Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sanofi-Aventis Phenylpropanolamine Product Portfolio Table 96. Sanofi-Aventis Recent Development Table 97. Roemmers Company Information Table 98. Roemmers Business Overview Table 99. Roemmers Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Roemmers Phenylpropanolamine Product Portfolio Table 101. Roemmers Recent Development Table 102. Riemser Pharma Company Information Table 103. Riemser Pharma Business Overview Table 104. Riemser Pharma Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Riemser Pharma Phenylpropanolamine Product Portfolio Table 106. Riemser Pharma Recent Development Table 107. Medlink Company Information Table 108. Medlink Business Overview Table 109. Medlink Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Medlink Phenylpropanolamine Product Portfolio Table 111. Medlink Recent Development Table 112. Meda Company Information Table 113. Meda Business Overview Table 114. Meda Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Meda Phenylpropanolamine Product Portfolio Table 116. Meda Recent Development Table 117. IBL Healthcare Company Information Table 118. IBL Healthcare Business Overview Table 119. IBL Healthcare Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. IBL Healthcare Phenylpropanolamine Product Portfolio Table 121. IBL Healthcare Recent Development Table 122. Helicon Company Information Table 123. Helicon Business Overview Table 124. Helicon Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Helicon Phenylpropanolamine Product Portfolio Table 126. Helicon Recent Development Table 127. Gräub Company Information Table 128. Gräub Business Overview Table 129. Gräub Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Gräub Phenylpropanolamine Product Portfolio Table 131. Gräub Recent Development Table 132. Gracia Pharmindo Company Information Table 133. Gracia Pharmindo Business Overview Table 134. Gracia Pharmindo Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Gracia Pharmindo Phenylpropanolamine Product Portfolio Table 136. Gracia Pharmindo Recent Development Table 137. Eipico Company Information Table 138. Eipico Business Overview Table 139. Eipico Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Eipico Phenylpropanolamine Product Portfolio Table 141. Eipico Recent Development Table 142. Carinopharm Company Information Table 143. Carinopharm Business Overview Table 144. Carinopharm Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Carinopharm Phenylpropanolamine Product Portfolio Table 146. Carinopharm Recent Development Table 147. Asuncion Company Information Table 148. Asuncion Business Overview Table 149. Asuncion Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Asuncion Phenylpropanolamine Product Portfolio Table 151. Asuncion Recent Development Table 152. Armoxindo Company Information Table 153. Armoxindo Business Overview Table 154. Armoxindo Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Armoxindo Phenylpropanolamine Product Portfolio Table 156. Armoxindo Recent Development Table 157. North America Phenylpropanolamine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. North America Phenylpropanolamine Sales by Country (2021-2026) & (K Units) Table 159. North America Phenylpropanolamine Sales Market Share by Country (2021-2026) Table 160. North America Phenylpropanolamine Sales Forecast by Country (2027-2032) & (K Units) Table 161. North America Phenylpropanolamine Sales Market Share Forecast by Country (2027-2032) Table 162. North America Phenylpropanolamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. North America Phenylpropanolamine Market Size by Country (2021-2026) & (US$ Million) Table 164. North America Phenylpropanolamine Market Share by Country (2021-2026) Table 165. North America Phenylpropanolamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. North America Phenylpropanolamine Market Share Forecast by Country (2027-2032) Table 167. Europe Phenylpropanolamine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Europe Phenylpropanolamine Sales by Country (2021-2026) & (K Units) Table 169. Europe Phenylpropanolamine Sales Market Share by Country (2021-2026) Table 170. Europe Phenylpropanolamine Sales Forecast by Country (2027-2032) & (K Units) Table 171. Europe Phenylpropanolamine Sales Market Share Forecast by Country (2027-2032) Table 172. Europe Phenylpropanolamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Europe Phenylpropanolamine Market Size by Country (2021-2026) & (US$ Million) Table 174. Europe Phenylpropanolamine Market Share by Country (2021-2026) Table 175. Europe Phenylpropanolamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Europe Phenylpropanolamine Market Share Forecast by Country (2027-2032) Table 177. Asia-Pacific Phenylpropanolamine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Asia-Pacific Phenylpropanolamine Sales by Country (2021-2026) & (K Units) Table 179. Asia-Pacific Phenylpropanolamine Sales Market Share by Country (2021-2026) Table 180. Asia-Pacific Phenylpropanolamine Sales Forecast by Country (2027-2032) & (K Units) Table 181. Asia-Pacific Phenylpropanolamine Sales Market Share Forecast by Country (2027-2032) Table 182. Asia-Pacific Phenylpropanolamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Asia-Pacific Phenylpropanolamine Market Size by Country (2021-2026) & (US$ Million) Table 184. Asia-Pacific Phenylpropanolamine Market Share by Country (2021-2026) Table 185. Asia-Pacific Phenylpropanolamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Asia-Pacific Phenylpropanolamine Market Share Forecast by Country (2027-2032) Table 187. Latin America Phenylpropanolamine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 188. Latin America Phenylpropanolamine Sales by Country (2021-2026) & (K Units) Table 189. Latin America Phenylpropanolamine Sales Market Share by Country (2021-2026) Table 190. Latin America Phenylpropanolamine Sales Forecast by Country (2027-2032) & (K Units) Table 191. Latin America Phenylpropanolamine Sales Market Share Forecast by Country (2027-2032) Table 192. Latin America Phenylpropanolamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Latin America Phenylpropanolamine Market Size by Country (2021-2026) & (US$ Million) Table 194. Latin America Phenylpropanolamine Market Share by Country (2021-2026) Table 195. Latin America Phenylpropanolamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Latin America Phenylpropanolamine Market Share Forecast by Country (2027-2032) Table 197. Middle East and Africa Phenylpropanolamine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 198. Middle East and Africa Phenylpropanolamine Sales by Country (2021-2026) & (K Units) Table 199. Middle East and Africa Phenylpropanolamine Sales Market Share by Country (2021-2026) Table 200. Middle East and Africa Phenylpropanolamine Sales Forecast by Country (2027-2032) & (K Units) Table 201. Middle East and Africa Phenylpropanolamine Sales Market Share Forecast by Country (2027-2032) Table 202. Middle East and Africa Phenylpropanolamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 203. Middle East and Africa Phenylpropanolamine Market Size by Country (2021-2026) & (US$ Million) Table 204. Middle East and Africa Phenylpropanolamine Market Share by Country (2021-2026) Table 205. Middle East and Africa Phenylpropanolamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 206. Middle East and Africa Phenylpropanolamine Market Share Forecast by Country (2027-2032) Table 207. Key Raw Materials Table 208. Raw Materials Key Suppliers Table 209. Phenylpropanolamine Distributors List Table 210. Phenylpropanolamine Customers List Table 211. Research Programs/Design for This Report Table 212. Authors List of This Report Table 213. Secondary Sources Table 214. Primary Sources List of Figures Figure 1. Phenylpropanolamine Image Figure 2. Global Phenylpropanolamine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phenylpropanolamine Market Size (2021-2032) & (US$ Million) Figure 4. Global Phenylpropanolamine Sales (2021-2032) & (K Units) Figure 5. Capsule Image Figure 6. Global Capsule Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tablet Image Figure 8. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. Syrup Image Figure 10. Global Syrup Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Phenylpropanolamine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Phenylpropanolamine Market Share by Type 2025 VS 2032 Figure 13. North America Phenylpropanolamine Sales Market Share in Volume by Type in 2025 Figure 14. North America Phenylpropanolamine Sales Market Share in Value by Type in 2025 Figure 15. Europe Phenylpropanolamine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Phenylpropanolamine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Phenylpropanolamine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Phenylpropanolamine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Phenylpropanolamine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Phenylpropanolamine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Phenylpropanolamine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Phenylpropanolamine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Phenylpropanolamine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Human Image Figure 26. Global Human Sales YoY Growth (2021-2032) & (K Units) Figure 27. Veterinary Image Figure 28. Global Veterinary Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Phenylpropanolamine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Phenylpropanolamine Market Share by Application 2025 VS 2032 Figure 31. North America Phenylpropanolamine Sales Market Share in Volume by Application in 2025 Figure 32. North America Phenylpropanolamine Sales Market Share in Value by Application in 2025 Figure 33. Europe Phenylpropanolamine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Phenylpropanolamine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Phenylpropanolamine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Phenylpropanolamine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Phenylpropanolamine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Phenylpropanolamine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Phenylpropanolamine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Phenylpropanolamine Sales Market Share in Value by Application in 2025 Figure 41. North America Phenylpropanolamine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Phenylpropanolamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Phenylpropanolamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Phenylpropanolamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Phenylpropanolamine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Phenylpropanolamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Phenylpropanolamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Phenylpropanolamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Phenylpropanolamine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Phenylpropanolamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Phenylpropanolamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Phenylpropanolamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Phenylpropanolamine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Phenylpropanolamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Phenylpropanolamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Phenylpropanolamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Phenylpropanolamine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Phenylpropanolamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Phenylpropanolamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Phenylpropanolamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Phenylpropanolamine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Phenylpropanolamine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Tablet
  • Syrup
Applications
  • Human
  • Veterinary
Companies covered
  • Abbott
  • GlaxoSmithKline (GSK)
  • Tempo Scan Pacific
  • Schazoo
  • Sanofi-Aventis
  • Roemmers
  • Riemser Pharma
  • Medlink
  • Meda
  • IBL Healthcare
  • Helicon
  • Gräub
  • Gracia Pharmindo
  • Eipico
  • Carinopharm
  • Asuncion
  • Armoxindo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Phenylpropanolamine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Phenylpropanolamine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Phenylpropanolamine Market by Type
  6. 1.3.1 Capsule
  7. 1.3.2 Tablet
  8. 1.3.3 Syrup
  9. 1.4 Global Phenylpropanolamine Market Size by Type
  10. 1.4.1 Global Phenylpropanolamine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Phenylpropanolamine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Phenylpropanolamine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Phenylpropanolamine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Phenylpropanolamine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Phenylpropanolamine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Phenylpropanolamine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Phenylpropanolamine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Phenylpropanolamine Industry Trends
  2. 2.2 Phenylpropanolamine Industry Drivers
  3. 2.3 Phenylpropanolamine Industry Opportunities and Challenges
  4. 2.4 Phenylpropanolamine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Phenylpropanolamine Revenue (2021-2026)
  2. 3.2 Global Top Players by Phenylpropanolamine Sales (2021-2026)
  3. 3.3 Global Top Players by Phenylpropanolamine Price (2021-2026)
  4. 3.4 Global Phenylpropanolamine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Phenylpropanolamine Major Company Production Sites & Headquarters
  6. 3.6 Global Phenylpropanolamine Company, Product Type & Application
  7. 3.7 Global Phenylpropanolamine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Phenylpropanolamine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Phenylpropanolamine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Phenylpropanolamine Tier 1, Tier 2, and Tier 3
4 Phenylpropanolamine Regional Status and Outlook
  1. 4.1 Global Phenylpropanolamine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Phenylpropanolamine Historic Market Size by Region
  3. 4.2.1 Global Phenylpropanolamine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Phenylpropanolamine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Phenylpropanolamine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Phenylpropanolamine Forecasted Market Size by Region
  7. 4.3.1 Global Phenylpropanolamine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Phenylpropanolamine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Phenylpropanolamine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Phenylpropanolamine by Application
  1. 5.1 Phenylpropanolamine Market by Application
  2. 5.1.1 Human
  3. 5.1.2 Veterinary
  4. 5.2 Global Phenylpropanolamine Market Size by Application
  5. 5.2.1 Global Phenylpropanolamine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Phenylpropanolamine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Phenylpropanolamine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Phenylpropanolamine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Phenylpropanolamine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Phenylpropanolamine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Phenylpropanolamine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Phenylpropanolamine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Phenylpropanolamine Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 GlaxoSmithKline (GSK)
  8. 6.2.1 GlaxoSmithKline (GSK) Company Information
  9. 6.2.2 GlaxoSmithKline (GSK) Business Overview
  10. 6.2.3 GlaxoSmithKline (GSK) Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline (GSK) Phenylpropanolamine Product Portfolio
  12. 6.2.5 GlaxoSmithKline (GSK) Recent Developments
  13. 6.3 Tempo Scan Pacific
  14. 6.3.1 Tempo Scan Pacific Company Information
  15. 6.3.2 Tempo Scan Pacific Business Overview
  16. 6.3.3 Tempo Scan Pacific Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tempo Scan Pacific Phenylpropanolamine Product Portfolio
  18. 6.3.5 Tempo Scan Pacific Recent Developments
  19. 6.4 Schazoo
  20. 6.4.1 Schazoo Company Information
  21. 6.4.2 Schazoo Business Overview
  22. 6.4.3 Schazoo Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Schazoo Phenylpropanolamine Product Portfolio
  24. 6.4.5 Schazoo Recent Developments
  25. 6.5 Sanofi-Aventis
  26. 6.5.1 Sanofi-Aventis Company Information
  27. 6.5.2 Sanofi-Aventis Business Overview
  28. 6.5.3 Sanofi-Aventis Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi-Aventis Phenylpropanolamine Product Portfolio
  30. 6.5.5 Sanofi-Aventis Recent Developments
  31. 6.6 Roemmers
  32. 6.6.1 Roemmers Company Information
  33. 6.6.2 Roemmers Business Overview
  34. 6.6.3 Roemmers Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Roemmers Phenylpropanolamine Product Portfolio
  36. 6.6.5 Roemmers Recent Developments
  37. 6.7 Riemser Pharma
  38. 6.7.1 Riemser Pharma Company Information
  39. 6.7.2 Riemser Pharma Business Overview
  40. 6.7.3 Riemser Pharma Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Riemser Pharma Phenylpropanolamine Product Portfolio
  42. 6.7.5 Riemser Pharma Recent Developments
  43. 6.8 Medlink
  44. 6.8.1 Medlink Company Information
  45. 6.8.2 Medlink Business Overview
  46. 6.8.3 Medlink Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Medlink Phenylpropanolamine Product Portfolio
  48. 6.8.5 Medlink Recent Developments
  49. 6.9 Meda
  50. 6.9.1 Meda Company Information
  51. 6.9.2 Meda Business Overview
  52. 6.9.3 Meda Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Meda Phenylpropanolamine Product Portfolio
  54. 6.9.5 Meda Recent Developments
  55. 6.10 IBL Healthcare
  56. 6.10.1 IBL Healthcare Company Information
  57. 6.10.2 IBL Healthcare Business Overview
  58. 6.10.3 IBL Healthcare Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 IBL Healthcare Phenylpropanolamine Product Portfolio
  60. 6.10.5 IBL Healthcare Recent Developments
  61. 6.11 Helicon
  62. 6.11.1 Helicon Company Information
  63. 6.11.2 Helicon Business Overview
  64. 6.11.3 Helicon Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Helicon Phenylpropanolamine Product Portfolio
  66. 6.11.5 Helicon Recent Developments
  67. 6.12 Gräub
  68. 6.12.1 Gräub Company Information
  69. 6.12.2 Gräub Business Overview
  70. 6.12.3 Gräub Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Gräub Phenylpropanolamine Product Portfolio
  72. 6.12.5 Gräub Recent Developments
  73. 6.13 Gracia Pharmindo
  74. 6.13.1 Gracia Pharmindo Company Information
  75. 6.13.2 Gracia Pharmindo Business Overview
  76. 6.13.3 Gracia Pharmindo Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Gracia Pharmindo Phenylpropanolamine Product Portfolio
  78. 6.13.5 Gracia Pharmindo Recent Developments
  79. 6.14 Eipico
  80. 6.14.1 Eipico Company Information
  81. 6.14.2 Eipico Business Overview
  82. 6.14.3 Eipico Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Eipico Phenylpropanolamine Product Portfolio
  84. 6.14.5 Eipico Recent Developments
  85. 6.15 Carinopharm
  86. 6.15.1 Carinopharm Company Information
  87. 6.15.2 Carinopharm Business Overview
  88. 6.15.3 Carinopharm Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Carinopharm Phenylpropanolamine Product Portfolio
  90. 6.15.5 Carinopharm Recent Developments
  91. 6.16 Asuncion
  92. 6.16.1 Asuncion Company Information
  93. 6.16.2 Asuncion Business Overview
  94. 6.16.3 Asuncion Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Asuncion Phenylpropanolamine Product Portfolio
  96. 6.16.5 Asuncion Recent Developments
  97. 6.17 Armoxindo
  98. 6.17.1 Armoxindo Company Information
  99. 6.17.2 Armoxindo Business Overview
  100. 6.17.3 Armoxindo Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Armoxindo Phenylpropanolamine Product Portfolio
  102. 6.17.5 Armoxindo Recent Developments
7 North America by Country
  1. 7.1 North America Phenylpropanolamine Sales by Country
  2. 7.1.1 North America Phenylpropanolamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Phenylpropanolamine Sales by Country (2021-2026)
  4. 7.1.3 North America Phenylpropanolamine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Phenylpropanolamine Market Size by Country
  6. 7.2.1 North America Phenylpropanolamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Phenylpropanolamine Market Size by Country (2021-2026)
  8. 7.2.3 North America Phenylpropanolamine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Phenylpropanolamine Sales by Country
  2. 8.1.1 Europe Phenylpropanolamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Phenylpropanolamine Sales by Country (2021-2026)
  4. 8.1.3 Europe Phenylpropanolamine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Phenylpropanolamine Market Size by Country
  6. 8.2.1 Europe Phenylpropanolamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Phenylpropanolamine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Phenylpropanolamine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Phenylpropanolamine Sales by Country
  2. 9.1.1 Asia-Pacific Phenylpropanolamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Phenylpropanolamine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Phenylpropanolamine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Phenylpropanolamine Market Size by Country
  6. 9.2.1 Asia-Pacific Phenylpropanolamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Phenylpropanolamine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Phenylpropanolamine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Phenylpropanolamine Sales by Country
  2. 10.1.1 South America Phenylpropanolamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Phenylpropanolamine Sales by Country (2021-2026)
  4. 10.1.3 South America Phenylpropanolamine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Phenylpropanolamine Market Size by Country
  6. 10.2.1 South America Phenylpropanolamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Phenylpropanolamine Market Size by Country (2021-2026)
  8. 10.2.3 South America Phenylpropanolamine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Phenylpropanolamine Sales by Country
  2. 11.1.1 Middle East and Africa Phenylpropanolamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Phenylpropanolamine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Phenylpropanolamine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Phenylpropanolamine Market Size by Country
  6. 11.2.1 Middle East and Africa Phenylpropanolamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Phenylpropanolamine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Phenylpropanolamine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Phenylpropanolamine Value Chain Analysis
  2. 12.1.1 Phenylpropanolamine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Phenylpropanolamine Production Mode & Process
  7. 12.2 Phenylpropanolamine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Phenylpropanolamine Distributors
  10. 12.2.3 Phenylpropanolamine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst